Ghazal Norouzi

Ghazal Norouzi

Auto-generated profile, based on publicly available information

Ghazal Norouzi

Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
PSPardis Soltanpoor
Pardis Soltanpoor
GNGhazal Norouzi
Ghazal Norouzi
Physicians should be alert about the possibility of subacute thyroiditis (SAT) being induced by COVID‐19 vaccination. SAT may present with anterior neck pain, extended fever or palpitation in recently vaccinated patients, which should not be easily dismissed as expected post‐vaccination flu‐like symptoms, thereby, facilitating in time diagnosis and treatment.

1 January 2015 in Journal of Ophthalmic and Vision Research
Verified
Journal Article
Open access
HSHamideh Sabbaghi
Hamideh Sabbaghi
ABAhmadShojaei Baghini
AhmadShojaei Baghini
MYMehdi Yaseri
Mehdi Yaseri
KSKoroush Sheibani
Koroush Sheibani
GNGhazal Norouzi
Ghazal Norouzi
ZRZhale Rajavi
Zhale Rajavi
The domain name Jovr.org is for sale. Call BuyDomains at 844-896-7299 to get a price quote and get your business online today!

1 January 2014 in Journal of Ophthalmic and Vision Research
Verified
Journal Article
Open access
ZRZhale Rajavi
Zhale Rajavi
HMHossein Moghadasifar
Hossein Moghadasifar
MFMohadese Feizi
Mohadese Feizi
NHNarges Haftabadi
Narges Haftabadi
MHMsreza Hadavand
Msreza Hadavand
GNGhazal Norouzi
Ghazal Norouzi
The domain name Jovr.org is for sale. Call BuyDomains at 844-896-7299 to get a price quote and get your business online today!

1 January 2015 in Journal of Ophthalmic and Vision Research
Verified
Journal Article
Open access
PDF file
HSHamideh Sabbaghi
Hamideh Sabbaghi
ZRZhale Rajavi
Zhale Rajavi
ABAhmad Shojaei Baghini
Ahmad Shojaei Baghini
MYMehdi Yaseri
Mehdi Yaseri
KSKoroush Sheibani
Koroush Sheibani
GNGhazal Norouzi
Ghazal Norouzi
Purpose: To determine the accuracy of photorefraction and autorefraction as compared to cycloautorefraction and to detect the repeatability of photorefraction. Methods: This diagnostic study included the right eyes of 86 children aged 7-12 years. Refractive status was measured using photorefraction (PlusoptiX SO4, GmbH, Nürnberg, Germany) and autorefraction (Topcon RM800, USA) with and without cycloplegia. Photorefraction for each eye was performed three times to assess repeatability. Results: The overall agreement between photorefraction and cycloautorefraction was over 81% for all refractive errors. Photorefractometry had acceptable sensitivity and specificity for myopia and astigmatism. There was no statistically significant difference considering myopia and astigmatism in all comparisons, while the difference was significant for hyperopia using both amblyogenic (P = 0.006) and nonamblyogenic criteria (P = 0.001). A myopic shift of 1.21 diopter (D) and 1.58 D occurred with photorefraction in nonamblyogenic and amblyogenic hyperopia, respectively. Using revised cut-off points of + 1.12 D and + 2.6 D instead of + 2.00 D and + 3.50 D improved the sensitivity of photorefractometry to 84.62% and 69.23%, respectively. The repeatability of photorefraction for measurement of myopia, astigmatism and hyperopia was acceptable (intra-cluster correlation [ICC]: 0.98, 0.94 and 0.77, respectively). Autorefraction results were significantly different from cycloautorefraction in hyperopia (P < 0.0001), but comparable in myopia and astigmatism. Also, noncycloglegic autorefraction results were similar to photorefraction in this study. Conclusion: Although photorefraction was accurate for measurement of myopia and astigmatism, its sensitivity for hyperopia was low which could be improved by considering revised cut-off points. Considering cut-off points, photorefraction can be used as a screening method.

1 June 2019 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
GNGhazal Norouzi
Ghazal Norouzi
RARamin Akbarian Aghdam
Ramin Akbarian Aghdam
HHHamidreza Hashemifard
Hamidreza Hashemifard
EPElahe Pirayesh
Elahe Pirayesh
A 68-year-old man with metastatic castration-resistant prostate cancer and widespread bone metastases as well as a history of kidney transplant, underwent 5 cycles of 177Lu–prostate-specific membrane antigen 617 therapies in our department. Being more cautious of the radiation burden imposed on the transplanted kidney, a lower average dose of 4 GBq per cycle was administered (instead of the more routine 6.0-7.4 GBq per cycle). However, excellent response was noted and serum creatinine level of 0.8 mg/dL remained stable.

21 January 2022 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
GNGhazal Norouzi
Ghazal Norouzi
ARAlireza Rezaei
Alireza Rezaei
ZAZohreh Adinehpour
Zohreh Adinehpour
HAHamidreza Amini
Hamidreza Amini
RVReza Vali
Reza Vali
A 59-year-old prostate cancer patient, status post radical prostatectomy, was referred to our department for restaging with 68Ga–prostate-specific membrane antigen (PSMA) PET/CT scan. Aside multiple metastatic lesions involving pelvic lymph nodes as well as the right femoral trochanter, a PSMA-positive rectal wall thickening was detected. Colonoscopy correlation and tissue diagnosis, recommended to rule out accompanying primary malignancy, confirmed the presence of rectal adenocarcinoma. This case signifies the importance of requesting pathological correlation for unexplained PSMA-positive lesions, emphasizing the potential role PSMA ligands may play in detecting occult second primary malignancies, especially synchronous/metachronous colorectal cancers.